Skip to content

Apotheek Meerbeek

Active
Private limited companyfounded 2006active for 20 yearsSchoonaardestraat 139, 3078 Kortenberg, BelgiumKBO/BCE: BE 0883.905.372

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Meerbeek has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €767,133 and a net result of €34,499. Equity is growing by about 4.9% per year across the filed financial years. Its solvency ranks better than 85% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek MeerbeekActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 25-09-2006 Normal situation
Legal form
Private limited company
Registered office
Schoonaardestraat 139, 3078 Kortenberg
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.156.623.764 3078 Kortenberg, since 11-10-2006
Financial year end
31 December
Peppol
Reachable
Company details

Who decides

Board
Board & ownership

How it is doing

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€190,451
▲ 69.7%
Turnover
≈ €890,000
estimated
Profit
€34,499
Equity
€767,133
▲ 4.7%
Total assets
€1.0m
▲ 1.7%
Staff
1 FTE
=
2025 accounts 29 days early
Filed on 02-07-2026at the National Bank
Financials
Why 96raises risk1 of the last 3 latelowers riskLiquidity: current ratio 2.61, cash €345,366Equity €767,133 (74.0% of total assets)Founded in 2006Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 69% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 99+2
equity 74.0% of total assets
Liquidity 82+4
short-term debt 25.7% · cash 33.3%
Profitability 73+44
return on assets 3.3%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: 0.1%▲ +0.1 percentage points vs 03-2025 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.3%▲ +0.1 percentage points vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.1%▼ -0.3 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.61, compared with 2.35 in 2024, above the usual 1.5; short-term debt: 25.7% and cash: 33.3% of total assets), and 26% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 84% on solvency, 85% on liquidity, 57% on profitability and 51% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.61, cash €345,366
NBB · annual accounts
lowers risk · Equity €767,133 (74.0% of total assets)
NBB · annual accounts
lowers risk · Founded in 2006
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · 1 of the last 3 late
NBB · filings
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 days early
2024
61 days late
2023
29 days late
2022
29 days late
2021
30 days late
2020
1 day early
2019
69 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 27 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Back in profit in 2025after -€51,269 in 2024 €34,499 View
  • Positive: Among the best 16% on solvencysector median 36.6% · 12,737 companies 74.0% View

Documents

Annual accounts at the NBB

All 19 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek Meerbeek

What is the company number of Apotheek Meerbeek?
0883.905.372. In Belgium the VAT number is the company number with BE in front: BE 0883.905.372.
Where is Apotheek Meerbeek based?
The registered office is at Schoonaardestraat 139, 3078 Kortenberg.Company details
What does Apotheek Meerbeek do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Meerbeek?
Private limited company (BV).
When was Apotheek Meerbeek founded?
On 25-09-2006.
Is Apotheek Meerbeek still active?
Yes, Apotheek Meerbeek is an active enterprise in the KBO register.
How many employees does Apotheek Meerbeek have?
On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Meerbeek?
≈ €890,000 in financial year 2025. Estimated from the gross margin of €190,451: probably between €600,000 and €1.7m, based on 51 comparable companies, NACE 477.
Is Apotheek Meerbeek profitable?
In financial year 2025, Apotheek Meerbeek made a profit of €34,499.
Where can I find the annual accounts of Apotheek Meerbeek?
Apotheek Meerbeek filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Apotheek Meerbeek due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Meerbeek

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure